# Ernexa Therapeutics Inc.: Form DEF 14A, filed Oct 7, 2024

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: DEF 14A
- Filed: 2024-10-07
- Accepted by EDGAR: Oct 7, 2024, 16:15 ET
- Period: 2024-10-07
- Accession: 0001493152-24-040286
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315224040286/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315224040286/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315224040286/formdef14a.htm

Filed Oct 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-040286. Last ingested by Listed: Oct 30, 2026, 14:05 ET. No prices; not investment advice.